M&A Deal Summary

Théa Acquires Akorn - Ophthalmic Products

On March 9, 2022, Théa acquired medical products company Akorn - Ophthalmic Products from Akorn

Acquisition Highlights
  • This is Théa’s 1st transaction in the Medical Products sector.
  • This is Théa’s 1st transaction in the United States.
  • This is Théa’s 1st transaction in Illinois.

M&A Deal Summary
Date 2022-03-09
Target Akorn - Ophthalmic Products
Sector Medical Products
Buyer(s) Théa
Sellers(s) Akorn
Deal Type Divestiture

Target

Akorn - Ophthalmic Products

Lake Forest, Illinois, United States
Akorn's Ophthalmic seven products include established glaucoma therapies Zioptan, Cosopt, Cosopt PF, and Betimol, along with Azasite, Akten, and the ocular surface repair agent AcellFX.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Théa

Clermont-Ferrand, France
Category Company
Sector Life Science
DESCRIPTION

Théa is an independent pharmaceutical company specialized in the research, development, and commercialization of eye-care products. Théa is based in Clermont-Ferrand, France.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1

Seller(S) 1

SELLER

Akorn

Lake Forest, Illinois, United States
Category Company
Founded 1971
Sector Life Science
Employees1,972
Revenue 1.1B USD (2016)
DESCRIPTION

Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.

DEAL STATS #
Overall 4 of 4
Sector (Medical Products) 2 of 2
Type (Divestiture) 3 of 3
State (Illinois) 2 of 2
Country (United States) 4 of 4
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-27 Akorn - Consumer Health Business

Lake Forest, Illinois, United States

Akorn's Consumer Health Business primarily consists of the following over-the-counter brands: TheraTears, Diabetic Tussin, MagOx, Multi-betic, and Zostrix. The business optimizes the core prescription drug portfolio and enhances our capacity to make growth-oriented investments.

Sell $230M
Mergr

Product

Company

Legal